Clinical Trials Directory

Trials / Sponsors / LigaChem Biosciences, Inc.

LigaChem Biosciences, Inc.

Industry · 14 registered clinical trials2 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors
Advanced Solid Tumors
Phase 1 / Phase 22026-08-01
Active Not RecruitingStudy to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus Complex
Nontuberculous Mycobacterium Infection, Mycobacterium Abscessus Infection
Phase 22024-01-16
RecruitingA Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tum
Advanced Solid Tumors
Phase 1 / Phase 22023-10-05
TerminatedA Phase 2a Study, Effect of Vancomycin With vs Without Delpazolid (LCB01-0371) in Patients With MRSA Bacteremi
MRSA Bacteremia
Phase 22022-04-26
CompletedPanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)
Infections and Infestations, Pulmonary Tuberculosis
Phase 22021-10-28
CompletedTrial to Evaluate Bioequivalence of LCB01-0371 in Different Batches
Healthy
Phase 12021-01-14
CompletedA Mass Balance Study of LCB01-0371 After a Single Oral LCB01-0371 Dose With a [14C]LCB01-0371-microtrace
Healthy
Phase 12020-06-21
CompletedA Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK
Pulmonary Tuberculosis
Phase 22016-12-10
CompletedIV Dosage Form of LCB01-0371 Phase I Study in Healthy Male Volunteers
Healthy
Phase 12016-09-01
CompletedTo Evaluate the Effect of Food on Pharmacokinetics(PK), Phase I Clinical Study of LCB01-0371
Healthy
Phase 12015-09-01
TerminatedAn Open-label, Single Dose, Parallel Design, Phase 1 Clinical Study of LCB01-0371
Healthy
Phase 12015-07-01
CompletedMultiple Ascending Dose, Phase 1 Clinical Study of LCB01-0371
Healthy
Phase 12014-06-01
CompletedMultiple Ascending Dose Study for LCB01-0371
Healthy
Phase 12013-03-01
CompletedA Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study
Healthy
Phase 12012-03-01